iLumi Biomed banner
Commercialization Capabilities

Capabilities

iLumi Biomed connects scientific innovation with commercial execution through licensing, regulatory alignment, distribution readiness, partner diligence, and U.S. market-access support.

Commercialization capabilities

Global Market
Access

Global Market Access

Connecting international life sciences innovators with U.S. commercialization pathways, strategic market-entry planning, qualified partners, and scalable commercial expansion opportunities.

Commercialization
Strategy

Commercialization Strategy

Developing commercialization pathways, launch positioning, market-entry planning, channel alignment, and partner-focused execution strategies for U.S. market readiness.

Deal Structure
& Licensing

Deal Structure and Licensing

Supporting licensing strategy, commercial deal structuring, strategic partnerships, diligence preparation, and transaction-aligned opportunity development initiatives.

GMP Manufacturing
Readiness

GMP Manufacturing Readiness

Coordinating GMP manufacturing readiness, CDMO and CMO evaluation, operational planning, production scalability, and commercialization support preparation.

Regulatory
Readiness

Regulatory Readiness

Commercialization planning informed by regulatory positioning, documentation discipline, submission awareness, pathway alignment, and execution-focused readiness support.

Distribution
& Cold Chain

Distribution and Cold Chain

Supporting logistics coordination, cold-chain planning, fulfillment strategy, inventory alignment, and commercialization-focused distribution readiness infrastructure.

How iLumi supports partner execution

iLumi Biomed helps translate promising life sciences assets into structured commercial opportunities by aligning technical documentation, commercialization goals, regulatory considerations, and partner expectations before market-facing engagement.

01 AssessmentReview of product, platform, evidence, documentation, commercial fit, and partner-readiness materials.
02 ArchitectureDesign of licensing, commercialization, distribution, regulatory, and strategic partnership pathways.
03 ExecutionSupport for introductions, diligence, negotiation structure, and commercialization readiness.

Partner with iLumi Biomed

Begin a structured U.S. commercialization, licensing, or strategic partnership discussion.

Request a partnering discussion